Navigation Links
Marshall Norris Joins NavigatorMD as Director of Business Development and Sales
Date:7/2/2008

KNOXVILLE, Tenn., July 2 /PRNewswire/ -- NavigatorMD, Inc., a leading 'benefits intelligence' software company providing integrated healthcare plan analytics in support of Value-Based Plan Design development, announced the addition of Marshall A. Norris as Director, Business Development and Sales.

Norris brings 24 years of experience in healthcare related insurance and technology, including market development and management. As Director of Business Development and Sales, he will provide leadership in all areas associated with market expansion.

Most recently, Norris served as a consultant for Willis, a global risk management company. Previously, he co-founded Sourceworks ClaimsPay, a pioneering HIPAA compliant electronic claims payment firm connecting Insurance Payers, Medical Providers and Claimants. His bio also includes Vice President with the Heusinkveld Group developing business opportunities in the self-funded reinsurance market, Regional Director with Highmark Insurance Group and Regional Manager with Boston Mutual Life.

"We are excited to welcome Marshall to our organization," said Ernest Youngblood, President and CEO of NavigatorMD, Inc. "Value-Based Plan Design is a new paradigm for controlling health care costs. It is a focused commitment on better health as an outcome. NavigatorMD software integrates health care data in the right way, for the right results, through plan design -- paving the way for more effective interventions, improved health of plan members, and lower health care costs -- resulting in greater workforce productivity. Marshall's wide range of industry knowledge and expertise with employee benefits, and experience associated with strategic market development will provide valuable leadership for our expanding team."

About NavigatorMD

NavigatorMD, Inc., created to empower the transformation of Healthcare in America, is accelerating change in the way healthcare benefit plans are delivered, measured, m
'/>"/>

SOURCE NavigatorMD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Modern Healthcare Names Marshall Erdman Nations Top Design-Build Company
2. Cogdell Spencer Inc. Announces the Closing of the Marshall Erdman and Associates Merger
3. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
4. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
5. Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence
6. Susan G. Komen for the Cure and Norris Cotton Cancer Center Bring Together 2008 Presidential Spouses, Doctors, Researchers and Advocates at Leadership Summit on Breast Cancer
7. Dr. Howard Epstein Joins Blue Cross as Medical Director for Commercial Operations and Clinical Design
8. Uroplasty Joins the Russell Microcap Index
9. Marc Andreessen Joins Facebook Board of Directors
10. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
11. Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... entered into an agreement with one of the ... drug candidates for the detection and treatment of ... novel antibody discovery and Roche,s expertise in developing ... possibility of improved treatment for cancer, a leading ... makes use of BTI,s discovery of a new ...
(Date:7/14/2014)... Florida (PRWEB) July 14, 2014 Botanica ... Open House event will be held at the day ... July 16th from 4-8pm. Wine and other refreshments will ... of retail discounts on beauty products and ... treatment known as dermaplaning. , Dermaplaning (also known ...
(Date:7/14/2014)... Barbara Bronson Gray ... (HealthDay News) -- New research suggests that a faltering ... Alzheimer,s disease, and that an inexpensive, low-tech smell test ... In two different studies, the decreased ability to ... cell function and progression to Alzheimer,s disease. "We,re ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July 14, 2014 (HealthDay ... have bigger brains and sharper thinking skills than their peers, ... between playing games such as puzzles, crosswords, cards and checkers ... Researchers found that people who played those games at ... and other mental functions. And, based on MRI scans, they ...
(Date:7/14/2014)... Atlanta, GA (PRWEB) July 14, 2014 ... networking and relationship-marketing firm, announced today that nominations ... for the 2014 Information Security Executive® (ISE®) North ... Security Executive® of the Year, which recognizes executives ... organizations through risk management, data-asset protection, regulatory compliance, ...
Breaking Medicine News(10 mins):Health News:A*STAR partners Roche to develop new cancer therapeutics 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3
... liver disease (NAFLD) is the most common cause of ... for patients with NAFLD is currently available//. Understanding the ... patients with NAFLD is important for patient counseling as ... ,To deal with these issues, researchers from Mayo Clinic ...
... genetically modified mosquito has been created that wipe out natural ... of the world such as India and South Asia. ... the wild in an attempt to combat malaria that is ... ,A similar attempt was made in India in 1970s ...
... to start its Phase III cancer vaccine trial against ... is the new skin cancer vaccine developed by Antigenics.// ... 322 patients failed to meet the required statistically significance ... was not shown to have any better results compared ...
... news for adults with acne and resultant facial scarring. ... Surgery, the medical journal of the American Society for ... - or non-ablative - lasers showed significant improvement of ... common with ablative procedures, such as facial resurfacing, dermabrasion ...
... survival rate of women with breast cancer has increased by ... years//. The experts feel that the increase in breast cancer ... detection of breast cancer and also due to more effective ... of cancer. ,Professor Michel Coleman, Epidemiologist, Cancer Research ...
... found that it is better to insert drug-coated stents ... who have diabetes//. ,The study author Dr. ... University Hospital in Madrid said that the results of ... have poorer prognosis as compared to non-diabetics after angioplasty. ...
Cached Medicine News:Health News:Weight reduction by 5% may help in treating nonalcoholic fatty liver disease 2Health News:Breast cancer women has shown an increase in survival rates 2
(Date:7/14/2014)... Lumin Medical LLC, a healthcare IT provider, ... leading provider of on-demand patient tracking solutions and is ... to Franklin, Wis. ... and our mission is to provide visibility for the ... reduce costs," said James Hermann , President of ...
(Date:7/14/2014)... DIEGO , July 14, 2014  More than any ... their smartphones and tablet computers -- but their eyes don,t. ... have never needed before, and the eye has not evolved ... and what our eyes can do comfortably often results in ... collectively known as Digital Eye Strain. Now ZEISS has invented ...
(Date:7/14/2014)... EAGAN, Minn. , July 14, 2014  Today, ... Partners, announced that it acquired the assets of MicroTest ... MA.  The acquisition of MTL is the first step ... and chemistry laboratory services platform to support the medical ... be known as Accuratus Lab Services , a ...
Breaking Medicine Technology:Lumin Medical Purchases PatientTrak 2Lumin Medical Purchases PatientTrak 3New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3
... III Study for the Treatment of Advanced Prostate CancerPARSIPPANY, ... launch of a Phase IIIB clinical trial of degarelix ... antagonist approved by the U.S. Food and Drug Administration ... cancer. The announcement was made at ...
... Diagnostic ToolSUNNYVALE, Calif., April 27 Cepheid (Nasdaq: ... MTB/RIF as a CE IVD Mark product under the ... Devices. For the first time, European clinicians will have ... Mycobacterium tuberculosis (MTB) and resistance to rifampicin ...
Cached Medicine Technology:Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 3Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 4Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 6
... a low osmolar ionic dimer. Each ... meglumine, 196 mg of ioxaglate sodium ... disodium as a stabilizer. The solution ... each milliliter and provides 32% (320 ...
... IMAGOPAQUE is a non-ionic monomeric contrast ... in adults and children. After a decade ... 3.5 million examinations, IMAGOPAQUE has proven to ... effort in hundreds of radiology departments.Results from ...
... is a liver-specific contrast agent approved for ... Its introduction expands the Amersham Health portfolio ... injected intravenously, TESLASCAN aids in the detection, ... Imaging can begin within minutes of injection, ...
... a new Contrast Agent for ... of stabilized SF6 microbubbles. The ... between 1 and 10 m, ... 2 and 5 x 108 ...
Medicine Products: